Beginning January 1, 2025, The Joint Commission will implement new accreditation requirements for laboratories in response to evolving practices and technological advancements. These changes align with the updated proficiency testing analytes and performance standards outlined in the revised Clinical Laboratory Improvement Amendments of 1988 (CLIA).

Important updates to the accreditation requirements will include:

  • Laboratories must report proficiency testing results for microbiology organism identification at the highest level that corresponds to patient specimen results,
  • The satisfactory performance threshold for unexpected antibody detection will increase from 80 percent to 100 percent, and
  • Clarifications will be provided regarding tests included in the ban on improper proficiency testing referrals. 

According to the Joint Commission, a new Appendix E will be added to the Comprehensive Accreditation Manual for Laboratories (CAMLAB) to capture additional information related to the updated regulations and revised requirements. More information is also available on the Joint Commission’s Prepublication Standards webpage.

Our team of experienced lawyers and professionals at Norton Rose Fulbright will continue to follow updates from The Joint Commission. If you have any questions, please do not hesitate to contact us.



Contacts

Yvonne K. Puig
Yvonne K. Puig
Chief Integration Partner, Life Sciences and Healthcare, United States
Email
yvonne.puig@nortonrosefulbright.com
T: +1 512 536 2450
Jeff Wurzburg
Jeff Wurzburg
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
T: +1 210 270 9338
Kathleen Rubinstein
Kathleen Rubinstein
Senior Analyst, Health Care
Email
kathleen.rubinstein@nortonrosefulbright.com
T: +1 713 651 5279

Practice area:

Industry:

Recent publications

M&A Outlook 2025 Crop 3

Publication

M&A in the asset management and fund sector: Key themes for 2025

UK and European asset managers have been facing considerable headwinds over the past few years.

Global | March 04, 2025

Asset finance

Publication

PFAS : Tour d’horizon des principales nouveautés législatives

L’Union Européenne l’avait annoncé , le législateur français l’a fait : le 20 février 2025, l'Assemblée Nationale a adopté définitivement la proposition de loi restreignant la fabrication et la vente de produits contenant des PFAS2, que l’on surnomme les « polluants éternels ».

Global | March 03, 2025

wall

Publication

A new era of below-threshold merger enforcement in the EU

2025 started with a clear signal that EU national competition authorities (NCAs) will persist in seeking ways to assess M&A deals that fall below the relevant merger control thresholds.

Global | February 28, 2025

Merger control
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now